AUROPHARMA - Aurobindo Pharma

Aurobindo Pharma

AUROPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: K Ragunathan · MD: N Govindarajan · Listing date: June 14, 1995 · Employees: 19364 · Hyderabad · http://www.aurobindo.com

Stock Price vs Company Growth

2.3%

15.7%

20.8%

0.8%

15.7%

24.1%

10y

8.7%

all

17.9%

🤔 How to analyze this graph?

Last Traded Price

₹ 1,219 2.3%

1,218

1,593

Company Overview

Sales

30,295 Cr

Growth: 12.4%

Profit after Tax

3,582 Cr

Growth: 1.7%

Large Cap

70,800 Cr

P/E: 19.9x

Industry P/E: 35.5x

Fundamentals

Sales (Cr)	₹ 30,295
Growth	12.4%
EBITDA	21.3%
P/S	2.3x
Dividend	0.4%
P/E	19.9x
Book Value	₹ 544
PEG Ratio	1.6x
ROE	11.8%
P/B	2.3x

Shareholding Pattern

Institutions

Life Insurance Corporation Of India

3.46 %

Hdfc Trustee Company Limited-Hdfc Flexi Cap Fund

3.4 %

Qualified Institutional Buyer

1.95 %

Nippon Life India Trustee Ltd-A/C Nippon India Pharma Fund

1.32 %

Bnp Paribas Arbitrage

1.22 %

Promoters

Rpr Sons Advisors Private Limited, Mrs.P.Suneela Rani (Jointly Holding)

33.51 %

K Nityananda Reddy

4.33 %

Kirthi Reddy Kambam

3.49 %

Venkata Ramprasad Reddy Penaka

3.07 %

Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.Ltd. (Jointly Holding)

2.85 %

Others

Increase Decrease No change

Company Profile Detailed

Aurobindo Pharma continues to be one of the world’s fastest growing Active Pharmaceutical Ingredients (API) manufacturing companies, driven by cost leadership, flexibility to produce multiple products in the same manufacturing facilities and capabilities in various therapeutic domains. Its API business has ensured the profitability and growth of its formulations business through seamless vertical integration.

Belongs to (35 Indices) view more

Investors (196)

aditya.b...

hdfc.tru...

Followers (73)

nitin2

keerthi

deepak